PDF(1234 KB)
PDF(1234 KB)
PDF(1234 KB)
胆囊息肉样病变诊治策略争议与共识
Consensus and controversies in the diagnosis and management strategies of polypoid lesions of gallbladder
胆囊息肉样病变(PLG)是常见的胆囊良性疾病,目前国内外指南或共识在以超声作为首选诊断方法、恶变风险分层及以最大径≥10 mm作为基本手术阈值等方面已形成共识,但在手术指征的界定以及随访管理策略方面仍存在一定争议,面临术前鉴别困难、低危息肉管理不明确及过度手术等问题及挑战。当前,个体化评估成为平衡过度医疗与漏诊恶变的关键,需结合风险分层进行动态监测与干预,提高PLG诊疗及随访管理的精准化水平。随着人工智能等技术发展,PLG的精准诊疗体系有望逐步完善。
Polypoid lesions of gallbladder (PLG) are common benign gallbladder diseases. Although current domestic and international guidelines have reached consensus on using ultrasonography as the primary diagnostic approach, stratification of malignant risk, and generally adopting a diameter of ≥10 mm as the basic surgical threshold, certain controversies persist regarding the definition of surgical indications and follow-up management strategies. Problems and challenges include difficulties in preoperative differentiation, unclear management of low-risk polyps, and potential unnecessary surgeries. Currently, individualized assessment has become key to balancing “over-treatment” and “missed diagnosis of malignancy,” necessitating dynamic monitoring and intervention based on risk stratification to enhance the precision of PLG diagnosis, treatment, and follow-up management. With advancements in technologies such as artificial intelligence, the precision medicine system for PLG is expected to be progressively refined in the future.
胆囊息肉样病变 / 手术指征 / 个体化诊疗 / 争议 / 共识
polypoid lesions of gallbladder / surgical indications / personalized management / controversies / consensus
| [1] |
|
| [2] |
Polyp size of 10 mm is insufficient to discriminate neoplastic and non-neoplastic risk in patients with gallbladder polyps (GPs). The aim of the study is to develop a Bayesian network (BN) prediction model to identify neoplastic polyps and create more precise criteria for surgical indications in patients with GPs lager than 10 mm based on preoperative ultrasound features.A BN prediction model was established and validated based on the independent risk variables using data from 759 patients with GPs who underwent cholecystectomy from January 2015 to August 2022 at 11 tertiary hospitals in China. The area under receiver operating characteristic curves (AUCs) were used to evaluate the predictive ability of the BN model and current guidelines, and Delong test was used to compare the AUCs.The mean values of polyp cross-sectional area (CSA), long, and short diameter of neoplastic polyps were higher than those of non-neoplastic polyps (P < 0.0001). Independent neoplastic risk factors for GPs included single polyp, polyp CSA ≥ 85 mm, fundus with broad base, and medium echogenicity. The accuracy of the BN model established based on the above independent variables was 81.88% and 82.35% in the training and testing sets, respectively. Delong test also showed that the AUCs of the BN model was better than that of JSHBPS, ESGAR, US-reported, and CCBS in training and testing sets, respectively (P < 0.05).A Bayesian network model was accurate and practical for predicting neoplastic risk in patients with gallbladder polyps larger than 10 mm based on preoperative ultrasound features.© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
|
| [3] |
朱连华, 费翔, 韩鹏, 等. 超声造影在胆固醇性息肉和胆囊腺瘤中的鉴别诊断价值[J]. 中国医学科学院学报, 2021, 43(3):350-356.DOI: 10.3881/j.issn.1000-503X.13791.
目的 比较超声造影(CEUS)与常规超声在胆固醇性息肉和胆囊腺瘤鉴别诊断中的准确性。方法 回顾性分析2019年1月至2020年10月在中国人民解放军总医院第一医学中心行胆囊切除术的136例胆囊息肉样病变(GPLs)患者的临床资料,比较胆固醇性息肉与胆囊腺瘤的超声及CEUS图像特征,评估CEUS的诊断准确性。结果 136例GPLs患者中,胆固醇性息肉患者95例,胆囊腺瘤患者41例。息肉最大径(Z=-5.189,Pχ <sup>2</sup>=33.630,PZ=-7.366,Pχ <sup>2</sup>=22.487,Pχ <sup>2</sup>=44.371,Pχ <sup>2</sup>=53.814,Pχ <sup>2</sup>=13.277,P=0.001)在胆固醇性息肉和胆囊腺瘤间的差异均有统计学意义。CEUS诊断胆囊腺瘤的敏感性、特异性和准确性分别是85.37%、89.47%和88.24%,曲线下面积为0.874。结论 CEUS能有效鉴别胆固醇性息肉和胆囊腺瘤,有助于GPLs患者选择合适的治疗方式。
|
| [4] |
\n \n \n \n Primary investigation of polypoid lesions of the gallbladder should be with abdominal ultrasound. Routine use of other imaging modalities is not recommended presently, but further research is needed. In centres with appropriate expertise and resources, alternative imaging modalities (such as contrast-enhanced and endoscopic ultrasound) may be useful to aid decision-making in difficult cases. Strong recommendation, low–moderate quality evidence.
|
| [5] |
|
| [6] |
中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科医师委员会. 胆囊良性疾病外科治疗的专家共识(2021版)[J]. 中华外科杂志, 2022, 60(1):4-9.DOI:10.3760/cma.j.cn112139-20210811-00373.
|
| [7] |
Incidental findings are commonly detected during examination of the gallbladder. Differentiating benign from malignant lesions is critical because of the poor prognosis associated with gallbladder malignancy. Therefore, it is important that radiologists and sonographers are aware of common incidental gallbladder findings, which undoubtedly will continue to increase with growing medical imaging use. Ultrasound is the primary imaging modality used to examine the gallbladder and biliary tree, but contrast-enhanced ultrasound and MRI are increasingly used. This review article focuses on two common incidental findings in the gallbladder; adenomyomatosis and gallbladder polyps. The imaging features of these conditions will be reviewed and compared between radiological modalities, and the pathology, epidemiology, natural history, and management will be discussed.
|
| [8] |
吴咏轩. 彩色多普勒超声检查对胆囊息肉样病变的鉴别诊断价值[J]. 现代医用影像学, 2024, 33(12):2311-2313. DOI: 10.3969/j.issn.1006-7035.2024.12.036.
|
| [9] |
贾丽刚, 费翔, 经翔, 等. 超声造影鉴别诊断胆囊息肉样病变性质的多中心研究[J]. 中国医学影像学杂志, 2024, 32(11):1147-1154. DOI: 10.3969/j.issn.1005-5185.2024.11.010.
|
| [10] |
|
| [11] |
李起, 袁嘉玮, 张东, 等. 胆囊息肉样病变的外科诊疗争议与策略[J]. 中华肝脏外科手术学电子杂志, 2025, 14 (2):181-186. DOI:10.3760/cma.j.cn115610-20250402-00133.
|
| [12] |
南令西, 倪晓凌. 5例胆囊腺肌症来源的意外胆囊癌报道[J]. 中华肝胆外科杂志, 2022, 28(5):385-387. DOI:10.3760/cma.j.cn113884-20211207-00403.
|
| [13] |
中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科专业委员会. 胆囊癌诊断和治疗指南(2019版)[J]. 中华外科杂志, 2020, 58(4):243-251.DOI:10.3760/cma.j.cn112139-20200106-00014.
|
| [14] |
|
| [15] |
赵海鹰. 胆囊良性疾病规范化诊治在胆囊癌防治中的意义[J]. 中国实用外科杂志, 2023, 43 (11):1295-1298. DOI:10.19538/j.cjps.issn1005-2208.2023.11.20.
|
| [16] |
何开举, 吴向嵩, 龚伟. 《IHPBA-APHPBA临床实践指南:国际德尔菲胆囊癌共识推荐》解读[J]. 中国实用外科杂志, 2025, 45(3):260-265.DOI:10.19538/j.cjps.issn1005-2208.2025.03.04.
|
| [17] |
中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科医师委员会. 胆囊良性疾病外科治疗的专家共识(2021版)[J]. 中华外科杂志, 2022, 60(1):4-9. DOI:10.3760/cma.j.cn112139-20210811-00373.
|
| [18] |
阮祥, 陈俊杰, 王向, 等. 《美国超声放射医师学会胆囊息肉管理共识(2022)》解读[J]. 中国实用外科杂志, 2022, 42(9): 1005-1009. DOI:10.19538/j.cjps.issn1005-2208.2022.09.12.
|
| [19] |
|
| [20] |
|
| [21] |
王恒杰, 张宝华, 顾卯林, 等. 意外胆囊癌的防范和外科治疗[J]. 肝胆胰外科杂志, 2021, 33(4):197-199+204.DOI:10.11952/j.issn.1007-1954.2021.04.002.
|
| [22] |
Cholecystectomy is performed for most gallbladder polyps (GPs). However, cholecystectomy results concerning complications in some patients. For benign GPs, adoption of gallbladder-preserving surgery is worth to recommend. We describe our experiences performing gallbladder-preserving polypectomy for GPs by embryonic-natural orifice transumbilical endoscopic surgery (E-NOTES) with a gastric endoscopy.
|
| [23] |
Gallbladder polyps are a common biliary tract disease whose treatment options have yet to be fully established. The indication of "polyps ≥ 10 mm in diameter" for cholecystectomy increases the possibility of gallbladder excision due to benign polyps. Compared to enumeration of risk factors in clinical guidelines, predictive models based on statistical methods and artificial intelligence provide a more intuitive representation of the malignancy degree of gallbladder polyps. Minimally invasive gallbladder-preserving polypectomy procedures, as a combination of checking and therapeutic approaches that allow for eradication of lesions and preservation of a functional gallbladder at the same time, have been shown to maximize the benefits to patients with benign polyps. Despite the reported good outcomes of predictive models and gallbladder-preserving polypectomy procedures, the studies were associated with various limitations, including small sample sizes, insufficient data types, and unknown long-term efficacy, thereby enhancing the need for multicenter and large-scale clinical studies. In conclusion, the emergence of predictive models and minimally invasive gallbladder-preserving polypectomy procedures has signaled an ever increasing attention to the role of the gallbladder and clinical management of gallbladder polyps.© 2023. The Author(s).
|
| [24] |
The first method of choice for gallbladder alteration detection is the conventional ultrasound. Due to some imaging limitations, contrast-enhanced ultrasound (CEUS) has been widely used in the last years. CEUS is an additional modality that is able to depict microvessels flow and elucidate suspicious findings.The aim of this retrospective mono-center analysis study is to evaluate the performance of CEUS in gallbladder diseases and compare it to cross-sectional imaging modalities and histopathological results as gold standard.The retrospective study analysed 37 patients with gallbladder diseases between 2009 and 2017. All patients underwent CEUS examinations and additional cross-sectional imaging was also performed: CT imaging on 24 (64.9%) patients, MRI imaging on 18 (48.6%) patients, CT and MRI imaging on (28.7%). CEUS images were performed and interpreted by a single physician.CEUS imaging results of the gallbladder showed a sensitivity and specificity of 100%, a positive predictive value (PPV) of 100% and a negative predictive value (NPV) of 100%. CT imaging of the gallbladder showed a sensitivity of 100%, specificity of 75%, PPV of 100%, and NPV of 95%. MR imaging of the gallbladder showed a sensitivity of 100%, specificity of 93%, PPV of 75%, and NPV of 100%.Ultrasound imaging plays an essential role in the evaluation of gallbladder disease. Due to additional features of contrast-enhanced ultrasound, it is possible to differentiate gallbladder pathologic alterations by depicting its micro and macrocirculation and display important malignant features that recommends prompt management. Patients with contraindications to other cross-sectional imaging modalities benefit from this safe technique.
|
| [25] |
Gallbladder (GB) polyp is a mucosal projection into the GB lumen. With increasing health awareness, GB polyps are frequently found using ultrasonography during health screening. The prevalence of GB polyps ranges between 1.3% and 9.5%. Most patients are asymptomatic and have benign characteristics. Of the nonneoplastic polyps, cholesterol polyps are most common, accounting for 60%-70% of lesions. However, a few polyps have malignant potential. Currently, the guidelines recommend laparoscopic cholecystectomy for polyps larger than 1 cm in diameter due to their malignan potential. The treatment algorithm can be influenced by the size, shape, and numbers of polyps, old age (>50 years), the presence of primary sclerosing cholangitis, and gallstones. This review summarizes the commonly recognized concepts on GB polyps from diagnosis to an algorithm of treatment.
|
| [26] |
|
| [27] |
|
| [28] |
A significant proportion of gallbladder polyps are non-neoplastic, for which resection is not necessary. However, international guidelines advocate cholecystectomy for all polyps ≥ 1 cm. This study assessed a national cohort of histopathologically proven gallbladder polyps to distinguish neoplastic from non-neoplastic polyps.PALGA, the nationwide network and registry of histo- and cytopathology, was searched to identify all histopathologically proven gallbladder polyps between 2003 and 2013. All polyps and (focal) wall thickenings > 5 mm were included, and classified as neoplastic or non-neoplastic. Polyp subtype, size, distribution, presentation as wall thickening or protruding polyp, and presence of gallstones were assessed for neoplastic and non-neoplastic polyps. A decision tree to distinguish neoplastic and non-neoplastic polyps was made and diagnostic accuracy of 1 cm surgical threshold was calculated.A total of 2085 out of 220,612 cholecystectomies contained a polyp (0.9%). Of these polyps, 56.4% were neoplastic (40.1% premalignant, 59.9% malignant) and 43.6% non-neoplastic (41.5% cholesterol polyp, 37.0% adenomyomatosis, 21.5% other). Polyp size, distribution, and presence of gallstones were reported in 1059, 1739 and 1143 pathology reports, respectively. Neoplastic polyps differed from non-neoplastic polyps in size (18.1 mm vs 7.5 mm, p < 0.001), singularity (88.2% vs 68.2%, p < 0.001), wall thickening (29.1% vs 15.6%, p < 0.001), and presence of gallstones (50.1% vs 40.4%, p = 0.001). However, adenomyomatosis presented with similar characteristics as neoplastic polyps. Fifty percent of polyps were ≥ 1 cm surgical threshold (optimal surgical threshold based on ROC-curve); sensitivity for indicating neoplastic polyps was 68.1%, specificity was 70.2%, and positive and negative predictive values were 72.9% and 65.1%.The prevalence of gallbladder polyps on cholecystectomy is low and many of the polyps are non-neoplastic. Clinicopathological characteristics differ between neoplastic and non-neoplastic polyps in general, but these cannot properly indicate neoplasia. The 1 cm surgical threshold has moderate diagnostic accuracy and is insufficient to indicate surgery for neoplastic gallbladder polyps.
|
| [29] |
|
/
| 〈 |
|
〉 |